Astera Labs, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 |
|---|---|---|---|---|
| Revenue | $852.5M | $396.3M | $115.8M | $79.9M |
| Gross profit | $645.3M | $302.7M | $79.8M | $58.7M |
| Operating income | $173.4M | -$116.1M | -$29.5M | -$60.2M |
| Operating expenses | $471.8M | $418.8M | $109.3M | $118.9M |
| Cost of revenue | $207.3M | $93.6M | $36.0M | $21.2M |
| Cash from operations | $319.3M | $136.7M | -$12.7M | -$35.9M |
| Capital expenditure | $37.5M | $34.2M | $2.8M | $3.9M |
| Free cash flow | $281.8M | $102.4M | -$15.5M | -$39.8M |
| Share repurchases | $0 | $1.1M | $210,000 | $313,000 |
| Impairments | $0 | $0 | $0 | — |
| Total assets | $1.5B | $1.1B | $196.3M | — |
| Total liabilities | $168.2M | $89.7M | $38.9M | — |
Shares outstanding 171.4M · Free float 89.6%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.